semaglutide doctor torrance ca Home | South Bay Medical Aesthetic Clinic, Inc Dr. Hicham Siouty, MD |

Preliminary research suggests that GLP-1s may improve menstrual regularity and increase fertility rates among people with obesity with hormonal disorders like polycystic ovarian syndrome (PCOS)

W., Cardinali, D

Among telehealth providers, Hims and Roman are two of the most popular out there

Our previous studies demonstrated that the transcription and translation of TAUT occur in cultured VSMCs 15

Proposed Escalation Strategy A theoretical cagrilintide and retatrutide combination protocol might follow this gradual escalation approach: Weeks 1-4: Foundation Phase Cagrilintide: 0.6 mg weekly Retatrutide: 2 mg weekly Focus: Establishing tolerance to both compounds Monitoring: Gastrointestinal effects, appetite changes Weeks 5-8: Escalation Phase Cagrilintide: 1.2 mg weekly Retatrutide: 4 mg weekly Focus: Increasing receptor activation Monitoring: Weight changes, metabolic markers Weeks 9-12: Optimization Phase Cagrilintide: 2.4 mg weekly Retatrutide: 8 mg weekly Focus: Approaching therapeutic targets Monitoring: Comprehensive metabolic assessment Weeks 13+: Maintenance Phase Cagrilintide: 3.0-4.5 mg weekly Retatrutide: 8-12 mg weekly Focus: Sustained metabolic effects Monitoring: Long-term safety and efficacy This graduated approach mirrors the successful strategies used in cagrilintide 10mg research protocols, where slow escalation minimizes side effects while building therapeutic benefit

As fat mass decreases, their production falls